Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 11/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 4/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1673754 | 0.89 | GPR119 (0.77) | GPR119MAPTGAAL3MBTL1ALDH1A1 | |
| SCHEMBL5260174 | 0.89 | GPR119 (0.67) | GPR119MAPTACACBLMNAALDH1A1 | |
| SCHEMBL5264529 | 0.88 | GPR119 (0.66) | GPR119MAPTACACBLMNAALDH1A1 | |
| SCHEMBL5267143 | 0.88 | GPR119 (0.59) | GPR119MAPTACACBLMNA | |
| SCHEMBL5263835 | 0.88 | GPR119 (0.78) | GPR119MAPTACACBLMNAALDH1A1 | |
| SCHEMBL5263099 | 0.88 | GPR119 (0.65) | GPR119MAPTACACBLMNAALDH1A1 | |
| SCHEMBL5263313 | 0.87 | GPR119 (0.79) | GPR119MAPTL3MBTL1ACACBLMNA | |
| SCHEMBL5264549 | 0.87 | GPR119 (0.67) | GPR119MAPTGAAACACBLMNA | |
| SCHEMBL5262168 | 0.87 | GPR119 (0.64) | GPR119MAPTACACBLMNAALDH1A1 | |
| SCHEMBL5259999 | 0.87 | GPR119 (0.69) | GPR119MAPTACACBLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599468-B1 | 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO SUCH AS DIABETES AND HYPERGLYCEMIA | ARENA PHARM INC (US) | 2007-10-03 | — | — | EP | claimed |